Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEDI:LX

62.90 EUR 0.22 0.35%

As of 00:59:30 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEDI)

Year To Date: +21.22% 3-Month: +13.46% 3-Year: +14.77% 52-Week Range: 47.65 - 63.43
1-Month: +3.92% 1-Year: +29.88% 5-Year: +9.46% Beta vs LUXXX: 0.59

Mutual Fund Chart for CARMEDI

No chart data available.
  • CARMEDI:LX 62.90
  • 1M
  • 1Y
Interactive CARMEDI Chart

Previous Close

Fund Profile & Information for CARMEDI

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-1998 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEDI

NAV (on 2013-05-21) 62.90
Assets (M) (on 2013-04-30) 460.37
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARMEDI

No dividends reported

Fees & Expenses for CARMEDI

Front Load -
Back Load -
Current Mgmt Fee 1.70
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEDI

Filing Date: 03/28/2013
Name Position Value % of Total
Pfizer Inc 1,672,359 37,519,872 8.166%
Roche Holding AG 177,900 32,417,437 7.055%
Novartis AG 424,216 23,531,945 5.122%
Gilead Sciences Inc 572,832 21,974,636 4.783%
Celgene Corp 230,387 20,883,536 4.545%
Merck & Co Inc 556,200 19,194,710 4.178%
Fresenius SE & Co KGaA 189,882 18,371,084 3.998%
Carnegie Fund V - The Carnegie 108,460 17,431,712 3.794%
UnitedHealth Group Inc 369,300 16,392,222 3.568%
DaVita HealthCare Partners Inc 139,000 12,809,931 2.788%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil